Inhibition of the alveolar macrophage oxidative burst by a diffusible component from the surface of the spores of the fungus Aspergillus fumigatus.

Seaton A, Robertson MD. Aspergillus, asthma and amoebae. Lancet 1989;893-894.

Bateman ED. A new look at the natural history of aspergillus hypersensitivity in asthmatics. Respir Med 1994;88:325-7.

Mullins J, Harvey R, Seaton A. Sources and incidence of airborne Aspergillusfumigatus. Clin Allergy 1976;6:209-17.

Waldorf AR, Lentz SM, Diamond RD. In vivo bronchoalveolar macrophage defence against Rhizopus oryzae and Aspergillus fumigatus. J' Infect Dis 1984;150:752-60.

Robertson MD, Seaton A, Milne LJR, Raeburn JA. Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells. Thorax 1987;42:466-72.

Robertson MD, Seaton A, Milne LJR, Raeburn JA. Suppression of host defences by Aspergillus fumigatus. Thorax 1987;42:19-25.

Robertson MD, Seaton A, Raebum JA, Milne LJR. Inhibition of phagocyte migration and spreading by spore diffusates of Aspergillus funzigatus. _7 Med Vet Mycol 1987; 25:389-96.

Robinson BWS, Venaille TJ, Mende AHW, McAleer R. Allergens as proteases: Aspergillus fumigattis protease directly induces human epithelial cell detachment. 7 Allergy Clitz Imnunol 1990;86:726-31.

Reichard, V. Buthner S. Eiffert H. Ruchel R. Purification and characterisation of an extracellular serine protease from Aspergillus funzigatus and its detection in tissue. Med Microbiol 1990;33:243-51.

Johnson RB, Godzik CA, Cohn ZA. Increased superoxide by immunologically activated and chemically elicited macrophages. 7 Exp Med 1978;148:115-27.

Dubois M, Gillies KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chern 1956;28:350-6.

Donaldson K, Bolton RE, Brown DM, Douglas A. An improved macrophage spreading assay - a simple and effective measure of activation. Inmnmunol Commun 1984; 13:229-44.

Perry FE, Elson CJ, Mitchell TJ, Andrew PW, Catterall JR. Characterisation of an oxidative response inhibitor produced by Streptococciis pneunioniae. Thorax 1994;49: 676-83.

Arruda KL, Mann BJ, Chapman MD. Selective expression of a major allergen and cytotoxin, Asp f I in Aspergillus fumigatus: implications for the immunopathogenesis of aspergillus-related diseases. _7 Inmmunol 1992;10:3354-9.

Sturtevant JE, Latge J-P. Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect Inimnun 1992;60:1913-8.

Waring P, Eichner RD, Tiwari-Palni U, Mullbacher A. The isolation and identification of a new metabolite from Aspergillus fiunigatus related to gliotoxin. Tetrahedroni Lett 1986;27:735-8.

Miillbacher A, Eichner RD. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. PNAS 1984;81:3835-7.

Mullbacher A, Waring P, Eichner RD. Identification of an agent in cultures of Aspergillus fumigatus displaying antiphagocytic and immunomodulating activity in vitro. Gen Microbiol 1985;13:1251-8.

Eichner RD, AlSalami M, Wood PR, Mullbacher A. The effect of gliotoxin upon macrophage function. Ilot 7 Immnzunopharmiacol 1986;8:789-97.

Reijula KE. Monoclonal antibodies bind identically to both spores and hyphae ofAspergillisfuwnigatus. Clin Exp Allergy 1992;22:547-53.

Cross A. Inhibitors of the leukocyte superoxide generating system. Free Radical Biol Med 1990;8:71-93.

Bastian NR, Hibbs JB. Assembly and regulation of NADPH oxidase and NO synthase. Curr Opin Biol 1994;6: 131-3.

Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of IKB-alpha proteolysis by site-specific, signal induced phosphorylation. Science 1995;267:1485-9.